Diversity of adaptive immune response is key biomarker for monitoring immune response.

Using Next Generation Sequencing (NGS), we have developed a quantitative unbiased technology allowing to monitor T-cell clonotypes (TCRseq) and diversity assessment on blood or solid tissue biological samples.